Analysis of KRAS/NRAS Mutations in a Phase III Study of Panitumumab with FOLFIRI Compared with FOLFIRI Alone as Second-line Treatment for Metastatic Colorectal Cancer
2015 ◽
Vol 21
(24)
◽
pp. 5469-5479
◽
Keyword(s):
Keyword(s):
2010 ◽
Vol 28
(15_suppl)
◽
pp. 3529-3529
◽
Keyword(s):
2008 ◽
Vol 26
(15_suppl)
◽
pp. 4064-4064
◽
Keyword(s):
2001 ◽
Vol 19
(5)
◽
pp. 1501-1518
◽
Keyword(s):
Keyword(s):
Keyword(s):
2005 ◽
Vol 23
(16_suppl)
◽
pp. 3525-3525
◽
Keyword(s):
Keyword(s):
2011 ◽
Vol 42
(2)
◽
pp. 134-138
◽
Keyword(s):
2016 ◽
Vol 34
(15_suppl)
◽
pp. TPS3625-TPS3625
◽
Keyword(s):